Oxidative Stress and DNA Epigenetic Modifications in Cancer: Mechanisms and Targeted Therapeutics
Open Access
- 9 April 2026
- journal article
- Published by Wiley in MedComm – Oncology
- Vol. 5 (2)
Abstract
Oxidative stress, defined as an imbalance between the production and clearance of reactive oxygen species (ROS), is not merely a reflection of metabolic or microenvironmental stress but an active signaling and regulatory hub in cancer. ROS function as key signaling molecules that drive tumorigenesis, metabolic reprogramming, and epigenetic remodeling. However, a systematic view of the spatiotemporally organized, bidirectional crosstalk between ROS and the DNA epigenetic machinery, particularly under conditions such as hypoxia, remains incomplete. This review synthesizes current understanding of this bidirectional axis. We detail how ROS reshape the DNA epigenetic landscape by modulating DNA methyltransferases and ten‐eleven translocation family protein (TET) dioxygenases, altering profiles of 5‐methylcytosine and its oxidized derivatives, and how epigenetic modifications in turn regulate ROS homeostasis through antioxidant and metabolic pathways. We further explore the cascade regulation of this interaction within the hypoxic tumor microenvironment and evaluate combined intervention strategies targeting both redox and epigenetic mechanisms. Emerging therapeutic avenues are highlighted, including spatiotemporally controlled ROS modulation, CRISPR‐based epigenome editing, ROS‐responsive proteolysis‐targeting chimeras, artificial intelligence (AI)‐driven multi‐omics prediction, and tissue‐specific delivery platforms. By integrating these insights, this review provides a framework for developing ROS‐guided precision epigenetic reprogramming strategies, offering novel therapeutic opportunities in cancer.Keywords
Funding Information
- National Natural Science Foundation of China (82403105)
- National Natural Science Foundation of China (82504086)
- Natural Science Foundation of Ningbo Municipality (2023J164)
- Natural Science Foundation of Chongqing Municipality (CSTB2024NSCQ‐MSX0889)
This publication has 390 references indexed in Scilit:
- Discovery of KW0113 as a First and Effective PROTAC Degrader of DNMT1 ProteinChemMedChem, 2024
- A Gene‐Switch Platform Interfacing with Reactive Oxygen Species Enables Transcription Fine‐Tuning by Soluble and Volatile Pharmacologics and Food AdditivesAdvanced Science, 2024
- Reactive oxygen species in biological systems: Pathways, associated diseases, and potential inhibitors—A reviewFood Science & Nutrition, 2023
- The thioredoxin system: Balancing redox responses in immune cells and tumorsEuropean Journal of Immunology, 2022
- Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's diseaseAlzheimer's & Dementia, 2022
- Epi‐immunotherapy for cancers: rationales of epi‐drugs in combination with immunotherapy and advances in clinical trialsCancer Communications, 2022
- Oxidative Stress in Cancer Therapy: Friend or Enemy?ChemBioChem, 2022
- Proteome‐Wide Profiling of Readers for DNA ModificationAdvanced Science, 2021
- Hypermethylation of Hepatic Mitochondrial ND6 Provokes Systemic Insulin ResistanceAdvanced Science, 2021
- Sequencing 5‐Hydroxymethyluracil at Single‐Base ResolutionAngewandte Chemie International Edition, 2018